Bupropion Impurity 38 | CAS 78969-41-2 - Request Quote
Bupropion Impurity 38
| SZ CAT No: | SZ-B001094 |
| CAS No | 78969-41-2 |
| Mol.F. | C9H8BrClO |
| Mol.Wt. | 245.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bupropion Impurity 38 is chemically 2-Bromo-3-chloro-1-phenylpropan-1-one. Bupropion Impurity 38 is supplied with detailed characterization data compliant with regulatory guideline. Bupropion Impurity 38 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupropion.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 78969-41-2
Purchase 78969-41-2
Order 78969-41-2
Enquire 78969-41-2
price of 78969-41-2
78969-41-2 Supplier
78969-41-2 Manufacturer
78969-41-2 Exporter
buy high quality Bupropion Impurity 38
Purchase Bupropion Impurity 38
Bupropion Impurity 38 suppliers
Bupropion Impurity 38 manufacturers
Bupropion Impurity 38 price
Order Bupropion Impurity 38
Enquire Bupropion Impurity 38
Bupropion Impurity 38 cost
Bupropion Impurity 38 Supplier
Bupropion Impurity 38 Distributor
Bupropion Impurity 38 for Method Validation
Bupropion Reference Standard
Bupropion Impurity 38 for ANDA Filing
Bupropion Impurity 38 for Forced Degradation Studies
Bupropion Impurity 38 Identification Standards
Bupropion Impurity 38 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.